U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07055295) titled 'Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen' on May 27.
Brief Summary: To demonstrate the immunogenicity of Sinovac rabies vaccine is non-inferior to the active-controlled rabies vaccine (Verorab(R)) after pre-exposure prophylaxis (PrEP) vaccination, and to confirm its satisfying safety profile in the pediatric and adult population in a PrEP schedule
Study Start Date: March 01, 2026
Study Type: INTERVENTIONAL
Condition:
Rabies
Intervention:
BIOLOGICAL: Rabies Vaccine (Serum-free Vero Cell), Freeze-dried
Receiving three doses of rabies vaccine rabies vaccine manufactu...